相关实验视频

Updated: May 3, 2026

Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction

Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction

Published on: April 1, 2019

甲状腺眼病中的特鲁马布与静脉注射甲基普雷迪尼索隆:系统性审查

Faizan Mehmood¹, Syed Ali Raza Rizvi², Sarah Alam³

¹Department of Ophthalmology, Aster Hospital Al Qusais, Dubai, UAE.

Oman journal of ophthalmology

|December 9, 2024

概括

一种较新的单克隆抗体Teprotumumab在甲状腺眼病 (TED) 中显示出比常规静脉注射甲基prednisolone (IVMP) 更好的结果. 这篇评论比较了它们在管理TED症状的有效性,例如proptosis和diplopia.

科学领域:

眼科医生眼科眼科
内分泌学在内分泌学.
免疫学免疫学免疫学

背景情况:

甲状腺眼病 (TED),或甲状腺相关的眼病,是一种自身免疫性疾病.
它涉及自身抗原,如甲状腺刺激激素受体和类似胰岛素的生长因子-I受体.
在临床上,TED是通过渐进性亡和双眼视的诊断.

研究的目的:

系统地审查和比较teprotumumab和静脉注射甲基prednisolone (IVMP) 治疗TED的疗效.
对标准治疗方案进行评估,以评估较新的治疗方案.

主要方法:

对2013年至2023年6月期间发表的研究进行系统审查.
选了329篇文章,确定了111篇没有重复的出版物.
在全文审查后,包括15项符合条件的研究,其中8项专注于teprotumumab.

主要成果:

在8项研究中使用了teprotumumab,而7项研究使用了标准治疗方法.
该审查评估了包括单克隆抗体teprotumumab和IVMP在内的治疗选择.
与传统的IVMP相比,teprotumumab在TED患者中表现出更好的结果.

结论:

在TED中,teprotumumab是一种有利的治疗选择.
与标准IVMP治疗相比,它提供了更好的结果.
进一步的研究支持teprotumumab在管理TED中的作用.

关键词:

抗体是对抗体的一种.坟墓眼科眼科眼科普得尼松是一种普得尼松.这就是为什么teprotumumab.甲状腺眼睛疾病甲状腺眼睛疾病

更多相关视频

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Published on: May 23, 2025

相关概念视频

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...